| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.52B | 30.03B | 23.79B | 26.87B | 21.49B | 20.98B |
| Gross Profit | 25.52B | 25.98B | 22.84B | 26.77B | 21.37B | 20.83B |
| EBITDA | 5.27B | 7.19B | 6.20B | 4.67B | 4.08B | 3.25B |
| Net Income | 4.03B | 4.36B | 4.01B | 3.07B | 2.66B | 2.11B |
Balance Sheet | ||||||
| Total Assets | 1.55T | 1.56T | 1.53T | 1.52T | 1.50T | 1.68T |
| Cash, Cash Equivalents and Short-Term Investments | 162.24B | 131.08B | 111.06B | 134.17B | 90.16B | 279.21B |
| Total Debt | 1.24B | 1.52B | 1.36B | 1.62B | 1.73B | 370.36B |
| Total Liabilities | 1.46T | 1.47T | 1.44T | 1.44T | 1.42T | 1.60T |
| Stockholders Equity | 87.72B | 95.02B | 86.46B | 86.04B | 75.27B | 75.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.56B | 4.71B | 0.00 | -212.06B | -31.48B |
| Operating Cash Flow | 0.00 | 13.75B | 5.29B | 0.00 | -210.95B | -30.53B |
| Investing Cash Flow | 0.00 | -22.29B | -4.99B | 71.83B | 22.79B | -5.78B |
| Financing Cash Flow | 0.00 | 19.66B | -1.90B | 17.86B | -546.00M | -591.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥25.70B | 9.58 | ― | 3.50% | 18.83% | 12.15% | |
70 Outperform | ¥42.29B | 10.00 | ― | 3.28% | 17.02% | 11.09% | |
68 Neutral | ¥52.40B | 8.14 | ― | 1.20% | 19.44% | 62.45% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥28.49B | 14.20 | ― | 2.59% | 17.44% | 9.43% | |
59 Neutral | ¥17.21B | 14.88 | ― | 3.37% | 6.15% | -0.87% | |
57 Neutral | ¥50.77B | -2.15 | ― | 2.87% | 26.62% | -664.91% |